Overview

A Study of Single and Multiple Doses of KW-6356 in Healthy Subjects

Status:
Completed
Trial end date:
2019-10-10
Target enrollment:
Participant gender:
Summary
Phase I study to assess the safety, tolerability and pharmacokinetics of single and multiple doses of KW-6356 in healthy volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Kyowa Hakko Kirin Co., Ltd
Kyowa Kirin Co., Ltd.